Science Focus on MSN
'It gives people more time to think': The strange effect of GLP-1s that's puzzling experts
There are striking new links between weight-loss drugs and impulse control ...
If your kid bullies one of their peers, you might be shocked. But it’s still possible to be instructive when your kids engage in unkind, even cruel, behavior.
With classes set to resume Aug. 10 across Las Vegas, many families are heading out this weekend for back-to-school shopping ...
An estimated 10 million Americans have atrial fibrillation (AFib), according to the National Institutes of Health's National ...
Chances are you're seen at least one ad for an "EOFY" sale already today. EOFY, an acronym for end of financial year, is a time when businesses offer discounts on products and sometimes encourage ...
A population study indicates that the link between impulsivity, alcohol, and violence falls by as much as 62% among users of these drugs Ozmepic and Mounjaro are two of the most popular weight-loss ...
A Rutgers study suggests GLP-1 drugs such as Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior. The surprising finding hints that these medications could affect ...
See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de búsqueda. Add The New York Times on GoogleAgrega The New York Times en Google On Sunday, ...
In the real world, a weak and insecure Donald Trump is being humiliated by Iran. Ah, but Sunday night, he’ll be a manly man among manly men. The president turns 80 on Sunday, and, as with everything ...
James Chen, CMT is an expert trader, investment adviser, and global market strategist. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced financial consultant. She has a demonstrated ...
At least four Russian military satellites changed their orbits to match that of a Finnish-American radar surveillance satellite in the last week, raising questions about Russia’s intentions amid an ...
A new study has found that an oral GLP-1 weight-loss medication called orforglipron (Foundayo) can help consumers maintain weight loss after coming off injectable forms of the medication. Recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results